Erschienen in:
01.04.2014 | Case Report
Successful isavuconazole salvage therapy in a patient with invasive mucormycosis
verfasst von:
J. Ervens, M. Ghannoum, B. Graf, S. Schwartz
Erschienen in:
Infection
|
Ausgabe 2/2014
Einloggen, um Zugang zu erhalten
Abstract
A 45-year-old male with rhinocerebral mucormycosis (Rhizopus oryzae), refractory to liposomal amphotericin B and posaconazole, received isavuconazole salvage therapy. Initial isavuconazole plasma and tissue levels were 0.76–0.86 μg/mL and 1.09–1.38 μg/g. Plasma levels increased to 1.3–3.24 μg/mL with reduced comedication. Isavuconazole was well tolerated, and the patient has remained disease-free 24 months post-antifungal therapy.